Safety Testing To Be Rushed/Streamlined/Skipped
Spiro Skouras is joined by Dr Andrew Kaufman, MD to discuss the coming CoVID-19 vaccine and the curtailment of basic civil liberties under the pretext of a global health emergency.
Here’s how an RNA vaccine works: rather than injecting a pathogen’s antigen into your body, you instead give the body the genetic code needed to produce that antigen itself. When the antigens appear on the outside of your cells, your immune system attacks them—and learns how to defeat future intruders in the process. You essentially turn your body into its own vaccine manufacturing unit.
Because RNA vaccines let your body do most of the work, they don’t require much material. That makes them much faster to manufacture. There’s a catch, though: we don’t know for sure yet if RNA is a viable platform for vaccines. Since COVID would be the first RNA vaccine out of the gate, we have to prove both that the platform itself works and that it creates immunity. It’s a bit like building your computer system and your first piece of software at the same time.” ~ Bill Gates
Note:: The rushed Covid-19 vaccine will not be a traditional vaccine. It will not be tested in any significant or standard capacity given the present state of emergency. It will be administered by the military, to "everyone on the planet." More
Health Risks Of Nanotech: How Nanoparticles Cause Lung Damage (Excerpt from the Science Daily aticle)
The US government safety research states nanomaterials may interact with the human body in different ways than more conventional materials, due to their extremely small size. For example, studies have established that the comparatively large surface area of inhaled nanoparticles can increase their toxicity. Such small particles can penetrate deep into the lungs and may move to other parts of the body, including the liver and brain.
Related article from Occupational Health and Safety in Australia: https://www.ohsrep.org.au/nanotechnology_-_a_new_hazard
Although most of the press coverage has been on the dangers of ‘nano-goo’ such as self-replicating particles that get out of control, or ‘nano-robots’, the real risks are much more simple, and real. The miniature size of nanomaterials and the way their surfaces are modified to increase the ease with which they can interact with biological systems – the very characteristics that make them attractive for applications in medicine and industry – makes nanomaterials potentially damaging for humans and the environment.
Nanoparticles are likely to be dangerous for three main reasons:
Nanoparticles may damage the lungs. We know that ‘ultra fine’ particles from diesel machines, power plants and incinerators can cause considerable damage to human lungs. This is both because of their size (as they can get deep into the lungs) and also because they carry other chemicals including metals and hydrocarbons in with them.
Nanoparticles can get into the body through the skin, lungs and digestive system. This may help create ‘free radicals’ which can cause cell damage and damage to the DNA. There is also concern that once nanoparticles are in the bloodstream they will be able to cross the blood-brain barrier.
The human body has developed a tolerance to most naturally occurring elements and molecules that it has contact with. It has no natural immunity to new substances and is more likely to find them toxic.
The danger of contact with nanoparticles is not just speculation. As more research is undertaken, concerns increase. Here are some of the recent findings:
With the FDA expected to grant emergency-use approval for the Pfizer-BionTech COVID vaccine Thursday after releasing a preliminary assessment of the trial data that the panel will use to assess the drug earlier today, the agency has admitted Tuesday that two participants in the Phase 3 trials have died. One of them was immunocompromised, according to the Jerusalem Post, citing data released earlier.
The FDA is expected to release two separate assessments of the trial data before a panel of experts meets to review the data and either approve Pfizer's request for emergency approval, or deny it.
This also comes after the FDA warned of a "severe averse reaction" frequently seen in patients after taking the second dose.
In the US, there has been at least one other trial participant who reportedly died not long after receiving the second dose. The participant in that case was a priest in Philadelphia who participated in the Moderna trial. In the UK, two patients were seriously sickened during the trial of the AstraZeneca-Oxford vaccine (though Oxford later said the illnesses had nothing to do with the trial). While In Brazil, authorities briefly halted a trial of Sinovac's experimental COVID vaccine after a participant died.
Source: ZeroHedge